Topical haemostatic agents for skin wounds: a systematic review

• Published in: BMC surgery Vol. 11; no. 1; p. 15
• Main Authors: Groenewold, Marieke D, Gribnau, Astrid J, Ubbink, Dirk T
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 12-07-2011; BioMed Central; BMC
• Subjects: Administration, Topical; Analysis; Care and treatment; Dermatologic agents; Dermatology; Diagnosis; Drug therapy; Formulae, receipts, prescriptions; Health aspects; Hemorrhage - drug therapy; Hemorrhage - etiology; Hemostasis; Hemostatics - administration & dosage; Humans; Skin - injuries; Wounds and injuries; Wounds and Injuries - complications; Wounds and Injuries - diagnosis; Netherlands
• ISSN: 1471-2482; 1471-2482
• DOI: 10.1186/1471-2482-11-15

Various agents and techniques have been introduced to limit intra-operative blood loss from skin lesions. No uniformity regarding the type of haemostasis exists and this is generally based on the surgeon's preference. To study the effectiveness of haemostatic agents, standardized wounds like donor site wounds after split skin grafting (SSG) appear particularly suitable. Thus, we performed a systematic review to assess the effectiveness of haemostatic agents in donor site wounds.
We searched all randomized clinical trials (RCTs) on haemostasis after SSG in Medline, Embase and the Cochrane Library until January 2011. Two reviewers independently assessed trial relevance and quality and performed data analysis. Primary endpoint was effectiveness regarding haemostasis. Secondary endpoints were wound healing, adverse effects, and costs.
Nine relevant RCTs with a fair methodological quality were found, comparing epinephrine, thrombin, fibrin sealant, alginate dressings, saline, and mineral oil. Epinephrine achieved haemostasis significantly faster than thrombin (difference up to 2.5 minutes), saline or mineral oil (up to 6.5 minutes). Fibrin sealant also resulted in an up to 1 minute quicker haemostasis than thrombin and up to 3 minutes quicker than placebo, but was not directly challenged against epinephrine. Adverse effects appeared negligible. Due to lack of clinical homogeneity, meta-analysis was impossible.
According to best available evidence, epinephrine and fibrin sealant appear superior to achieve haemostasis when substantial topical blood loss is anticipated, particularly in case of (larger) SSGs and burn debridement.